The Alliance of Specialty Medicine submitted comments to CMS on the CY 2027 Medicare Advantage (MA) and Part D Advance Notice, complementing its recent comments on the CY 2027 MA and Part D proposed rule. In the letter, the Alliance supported excluding diagnoses from unlinked chart reviews from MA risk score calculations while urging continued oversight of plan medical record request practices. The Alliance also encouraged CMS to strengthen the Star Ratings program with measures that address network adequacy, utilization management, and administrative burden. You can read the Alliance’s full comments at the link below.
